Outcomes of suction curettage and mifepristone abortion in the United States

Contraception - Tập 59 - Trang 153-159 - 1999
Jeffrey T Jensen1, Susan J Astley2, Elizabeth Morgan1, Mark D Nichols1
1Department of Obstetrics and Gynecology, Oregon Health Sciences University Portland, Oregon USA
2Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington, USA

Tài liệu tham khảo

Legarth, 1991, Mifepristone or vacuum aspiration in termination of early pregnancy, Eur J Obstet Gynecol Repro Bio, 41, 91, 10.1016/0028-2243(91)90085-Y Chan, 1993, Blood loss in termination of early pregnancy by vacuum aspiration and by combination of mifepristone and gemeprost, Contraception, 47, 85, 10.1016/0010-7824(93)90111-J Thong, 1992, What do women want during medical abortion?, Contraception, 46, 435, 10.1016/0010-7824(92)90147-L Holmgren, 1992, Women’s evaluation of three early abortion methods, Acta Obstet Gynecol Scand, 71, 616, 10.3109/00016349209006230 Urquhart, 1991, Psychiatric morbidity and acceptability following medical and surgical methods of induced abortion, Br J Obstet Gynecol, 98, 396, 10.1111/j.1471-0528.1991.tb13431.x Bachelot, 1992, Conditions for choosing between drug induced and surgical abortion, Contraception, 45, 547, 10.1016/0010-7824(92)90106-4 Winikoff, 1997, Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India, Am J Obstet Gynecol, 176, 431, 10.1016/S0002-9378(97)70511-8 Spitz, 1998, Early pregnancy termination with mifepristone and misoprostol in the United States, N Engl J Med, 338, 1241, 10.1056/NEJM199804303381801 Peyron, 1993, Early termination of pregnancy with mifepristone (RU486) and the orally active prostaglandin misoprostol, N Engl J Med, 328, 1509, 10.1056/NEJM199305273282101 Silvestre, 1990, Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue, N Engl J Med, 322, 645, 10.1056/NEJM199003083221001 Ullmann, 1992, Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women, Acta Obstet Gynecol Scand, 71, 278, 10.3109/00016349209021052 Norman, 1992, Medical abortion in women of less than or equal to 56 days amenorrhoea, Br J Obstet Gynecol, 99, 601, 10.1111/j.1471-0528.1992.tb13830.x Urquhart, 1997, The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study—final results, Contraception, 55, 1, 10.1016/S0010-7824(96)00252-1 Beckman, 1997, Experience and acceptability of medical abortion with mifepristone and misoprostol among U.S. women, Women Health Issues, 7, 253, 10.1016/S1049-3867(97)00117-5 el-Refaey, 1995, Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol, N Engl J Med, 332, 983, 10.1056/NEJM199504133321502 Creinin, 1997, Contraception, 56, 367, 10.1016/S0010-7824(97)00173-X Creinin, 1997, Medical abortion with oral methotrexate and vaginal misoprostol, Obstet Gynecol, 90, 611, 10.1016/S0029-7844(97)00266-4 Wiebe, 1997, Abortion induced with methotrexate and misoprostol, Contraception, 55, 159, 10.1016/S0010-7824(97)00021-8 Grimes, 1997, Medical abortion in early pregnancy, Obstet Gynecol, 89, 790, 10.1016/S0029-7844(97)81439-1